Clinical Trials Directory

Trials / Completed

CompletedNCT03760029

A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy

A NATURAL HISTORY STUDY IN CHINESE MALE PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
312 (actual)
Sponsor
Pfizer · Industry
Sex
Male
Age
0 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, prospective, single cohort study designed to describe the natural history of DMD in Chinese male patients. A total of approximately 330 subjects will be enrolled with the target number of subjects in each group as below: * Group 1, Ambulatory subjects aged \<6 years, approximately 100 subjects; * Group 2, Ambulatory subjects aged \>=6 years, approximately 180 subjects; * Group 3, Non-ambulatory subjects, approximately 50 subjects. Subjects will visit sites every 6 months. Each subject will be observed for at least 24 months. All subjects will remain enrolled until the study completion date, such that some will have data collected after Month 24. Subjects, who complete Visit 5/Month 24 at least 6 months prior to study completion, will be asked to complete an additional visit at Month 30.

Conditions

Interventions

TypeNameDescription
OTHERVisit frequencyAll subjects need to visit sites more frequently than in routine clinical practice.

Timeline

Start date
2019-07-24
Primary completion
2023-03-21
Completion
2023-03-21
First posted
2018-11-30
Last updated
2024-09-19
Results posted
2024-09-19

Locations

8 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03760029. Inclusion in this directory is not an endorsement.